ClinicalTrials.gg
CompletedNCT03241849Updated Jun 23, 2020

Surgical Technique To Control Postpartum Hemorrhage

An interventional study of Modified surgical technique for placenta accreta in Post Partum Hemorrhage, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2020-06-23.

Sponsored by Assiut University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Not applicable
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

Placenta accreta is an obstetrical complication where the placenta becomes firmly adherent to the uterine wall. Placenta accreta can lead to considerable maternal morbidity and mortality due to hemorrhage, infection, or other surgical complications such as those resulting from hysterectomy. Retained placenta accreta is usually a rare condition, but its prevalence is increasing due to the rise in the rate of deliveries by Cesarean section.

Placenta accreta is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management. The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate. Women at greatest risk of placenta accreta are those who have myometrial damage caused by a previous cesarean delivery with either an anterior or posterior placenta previa overlying the uterine scar. Diagnosis of placenta accreta before delivery allows multidisciplinary planning in an attempt to minimize potential maternal or neonatal morbidity and mortality.

02

Conditions studied

  • Post Partum Hemorrhage

Browse trials for

03

In context

Postpartum Hemorrhage

456 studies on the registry are indexed under Postpartum Hemorrhage; 77 are open to participants now.

This study's enrollment of 110 is below the median of 148 across 348 interventional studies indexed under Postpartum Hemorrhage.

Browse Postpartum Hemorrhage studies →

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Estimated gestational age between 34 -40 weeks .
  2. Presence of total or focal parts of placenta accreta "morbidly adherent placenta" .
  3. Cases with mild vaginal bleeding or not having any vaginal bleeding

Exclusion criteria

Exclusion Criteria:

  1. Severe attack of bleeding require an immediate intervention.
  2. Associated with placental abruption
  3. Patients with known bleeding disorders or on anticoagulant therapy.
  4. Preoperative decision to do peripartum hysterectomy.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Other
    Modified surgical technique for placenta accreta

    Procedure: Modified surgical technique for placenta accreta

Interventions

  • ProcedureModified surgical technique for placenta accreta

    suturing of the myometrium splitted by the placenta in cases presented by placenta accreta

06

What researchers measure

Primary outcomes

  1. Amount of blood loss (mL)

    Time frame: 24 hours

07

Study locations

1 site
  • Women Health Hospital - Assiut university
    Asyut, 71111, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03241849
Lead sponsor
Assiut University
Responsible party
Mohammed Khairy Ali (Dr, Assiut University) — Principal investigator
First posted
Aug 8, 2017
Start date
Aug 1, 2017
Primary completion
Jan 1, 2020
Completion
Feb 1, 2020
Last update
Jun 23, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion